Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kurt

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|July 14, 2020
Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantationP Ataca Atilla, E Akkus, E Atilla, et al.
Urologic Oncology|August 22, 2025
Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapyC N Sternberg, P Squifflet, E D Saad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experienceH Beköz, N Karadurmuş, S Paydaş, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|July 14, 2020
Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantationP Ataca Atilla, E Akkus, E Atilla, et al.
Urologic Oncology|August 22, 2025
Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapyC N Sternberg, P Squifflet, E D Saad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experienceH Beköz, N Karadurmuş, S Paydaş, et al.
Pageof 14